STOCK TITAN

Olink to participate in the 41st Annual JP Morgan Healthcare Conference

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) is set to participate in the 41st Annual JP Morgan Healthcare Conference on January 11, 2023, at 7:30 am PT. During this event, company management will present insights into Olink's commitment to advancing proteomics in collaboration with the scientific community. A live and archived webcast of the presentation will be accessible via the Company’s website. Founded in 2016, Olink is focused on enhancing understanding of human biology and supporting healthcare innovations.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OLK

+0.36%
+0.36% Session move

In the trading session that priced this news, OLK gained 0.36%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UPPSALA, Sweden, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced its participation in the 41st Annual JP Morgan Healthcare Conference.

Company management will present on Wednesday, January 11th, 2023 at 7:30 am PT.

A live and archived webcast of the event will be available on the “Events” section of the Company’s website at https://investors.olink.com/news-events/events.

About Olink
Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

IR contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com  

Media contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com


FAQ